Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery

被引:15
|
作者
Li, Changhui [1 ]
Shen, Yinchen [1 ]
Hu, Fang [1 ]
Chu, Tianqing [1 ]
Yang, Xiaohua [2 ]
Shao, Jinchen [3 ]
Zheng, Xiaoxuan [1 ]
Xu, Jianlin [1 ]
Zhang, Hai [1 ]
Han, Baohui [1 ]
Zhong, Hua [1 ]
Zhang, Xueyan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Cent Lab, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pathol, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
关键词
Lung adenocarcinoma; EGFR; Micropapillary; Brain metastases; Surgical resection; HISTOLOGIC SUBTYPE; CANCER PATIENTS; CLASSIFICATION; PROGNOSIS; IMPACT; CHEMOTHERAPY; RISK;
D O I
10.1016/j.lungcan.2020.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The role of micropapillary pattern (MIP) in EGFR-mutated NSCLC patients with brain metastases (BM) after complete surgical resection still remains unclear. Therefore, a retrospective study was conducted to evaluate the role of MIP in those patients. Methods: This study included 332 stage I-III patients with EGFR-mutant lung adenocarcinoma and complete resection. Patients were classified in four groups: the MIP-positive patients without BM development, the MIP-negative patients without BM development, the MIP-positive patients with BM development and the MIP-negative patients with BM development. Intracranial disease-free survival (iDFS), systemic disease-free survival (DFS) and overall survival (OS) were evaluated. Results: The median OS in the whole group was 70 months. The patients with MIP show inferior DFS (13 months vs. 22 months; P < 0.001) and OS (56 months vs. 74 months; P < 0.001). Furthermore, BM development was more likely to be found in patients with MIP (P = 0.001). In addition, the MIP-positive patients showed a significantly shorter iDFS compared with MIP-negative patients (14.5 months vs. 26 months; P < 0.001). Furthermore, the MIP-positive patients had significantly inferior iDFS in both BM as first line development groups (13 months vs. 19 months; P < 0.001) and BM as non-first line development groups (18 months vs. 33 months; P = 0.007). Conclusions: MIP was related to the earlier recurrence and shortened survival time. In addition, MIP was an independent poor prognostic factor for the increase of BM rate and the shortened time of BM development after surgery.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [1] Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival
    Stanic, Karmen
    Zwitter, Matjaz
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Cufer, Tanja
    RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 173 - 183
  • [2] A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?
    Han, Guang
    Bi, Jianping
    Tan, Wenyong
    Wei, Xueyan
    Wang, Xiaohong
    Ying, Xiaofang
    Guo, Xiaofang
    Zhou, Xiaoyi
    Hu, Desheng
    Zhen, Weining
    ONCOTARGET, 2016, 7 (35) : 56998 - 57010
  • [3] EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component
    Kang, Haixin
    Lv, Haiyan
    Tung, Tao-Hsin
    Ma, Dehua
    Wang, Zheng
    Du, Juping
    Zhou, Kai
    Pan, Juan
    Zhang, Yanjie
    Peng, Shuotao
    Yu, Zhaonan
    Shen, Bo
    Ye, Minhua
    ASIAN JOURNAL OF SURGERY, 2024, 47 (01) : 201 - 207
  • [4] Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patients
    Yomo, Shoji
    Oda, Kyota
    LUNG CANCER, 2018, 119 : 120 - 126
  • [5] Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases
    Xu, Jiali
    Yang, Yuqiong
    Gao, Zhizhen
    Song, Tao
    Ma, Yichuan
    Yu, Xiaojun
    Shi, Changzheng
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 240
  • [6] Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Li, Changhui
    Guo, Jindong
    Zhao, Lei
    Hu, Fang
    Nie, Wei
    Wang, Huimin
    Zheng, Xiaoxuan
    Shen, Yinchen
    Gu, Ping
    Zhang, Yujun
    Zhang, Xueyan
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3433 - 3443
  • [7] Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients
    Liu Chao
    Huang Yi-Sheng
    Chen Yu
    Yan Li-Xu
    Luo Xin-lan
    Luo Dong-Lan
    Chen Jie
    Wu Yi-Lon
    Liu Yan Hui
    LUNG CANCER, 2014, 86 (02) : 164 - 169
  • [8] EGFR Mutation Status Analysis in Cerebrospinal Fluid and Plasma of Advanced Lung Adenocarcinoma with Brain Metastases
    Shi, Liang
    Liu, Zhe
    Tang, Jungfang
    Wu, Hongbo
    Guo, Lili
    Li, Mingzhi
    Tong, Li
    Wu, Wei
    Tao, Hong
    Wu, Weihua
    Li, Hongxia
    Meng, Qiyi
    Xu, Liyan
    Zhu, Yunzhong
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S938 - S939
  • [9] Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery
    Xiong, Anning
    Li, Changhui
    Xu, Jianlin
    Yang, Xiaohua
    Nie, Wei
    Zhong, Hua
    Chu, Tianqing
    Zhang, Wei
    Zhong, Runbo
    Pan, Feng
    Shen, Yinchen
    Lou, Yuqing
    Zhang, Bo
    Han, Baohui
    Zhang, Xueyan
    LUNG CANCER, 2021, 154 : 124 - 130
  • [10] Prognostic Factors and Prediction of Survival for Patients with Brain Metastases of Lung Adenocarcinoma
    Zheng, Rongjiong
    Guo, Dina
    Dong, Yongquan
    Wang, Mingming
    Hu, Meiling
    Ren, Yifeng
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2021, 88 (04) : 319 - 325